Coherent Market Oriented Blogs

The rising prevalence of cancer is fostering the growth of the global proton therapy market. According to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in the year 2018. A growing number of healthcare facilities that offer proton therapy is again contributing to the growth of the market. For example, in February 2020, Illinois Health Facilities and Services Review Board approved the OSF HealthCare plan to construct a cancer care center that offers proton-beam therapy. Major players are focusing on expanding their presence across emerging economies which is further expected to accelerate the growth of the  proton therapy market . For instance, in February 2020, Ion Beam Applications S.A. signed a contract to install a ProteusONE compact proton therapy solution at the RSPAD Gatot Soebroto Presidential Hospital in Jakarta, Indonesia. In November 2019, Mevion Medical Systems signed an agreement with Chung Sha...

Proton therapy is the most exact and progressed type of radiation therapy and is fundamentally utilized in the therapy of malignant growth. It offers critical advantages over customary radiation therapy as far as viability and restricted results. It is an effortless, non-intrusive treatment that keeps up the personal satisfaction of patients and empowers them to rapidly continue ordinary exercises. It permits doctors to convey full or higher treatment doses that obliterate the fundamental tumor site without making hurt encompassing solid tissue or organs. As per The National Association for Proton Therapy, there are 25 focuses and 11 focuses are under development in U.S. giving proton therapy treatment across the United States, including UC Davis Crocker Lab, Indiana University Health Proton Therapy Center and M.D. Anderson Cancer Center; 8 new focuses are being created. Till date, in excess of 80,000 patients experiencing an assortment of malignant growths, for example, prostate disea...